Cargando…
Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series
BACKGROUND: Mitochondrial DNA depletion syndromes (MDS) are clinically and phenotypically heterogeneous disorders resulting from nuclear gene mutations. The affected individuals represent a notable reduction in mitochondrial DNA (mtDNA) content, which leads to malfunction of the components of the re...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819644/ https://www.ncbi.nlm.nih.gov/pubmed/31664948 http://dx.doi.org/10.1186/s12881-019-0893-9 |
_version_ | 1783463782398296064 |
---|---|
author | Mahjoub, Ghazale Habibzadeh, Parham Dastsooz, Hassan Mirzaei, Malihe Kavosi, Arghavan Jamali, Laila Javanmardi, Haniyeh Katibeh, Pegah Faghihi, Mohammad Ali Dastgheib, Seyed Alireza |
author_facet | Mahjoub, Ghazale Habibzadeh, Parham Dastsooz, Hassan Mirzaei, Malihe Kavosi, Arghavan Jamali, Laila Javanmardi, Haniyeh Katibeh, Pegah Faghihi, Mohammad Ali Dastgheib, Seyed Alireza |
author_sort | Mahjoub, Ghazale |
collection | PubMed |
description | BACKGROUND: Mitochondrial DNA depletion syndromes (MDS) are clinically and phenotypically heterogeneous disorders resulting from nuclear gene mutations. The affected individuals represent a notable reduction in mitochondrial DNA (mtDNA) content, which leads to malfunction of the components of the respiratory chain. MDS is classified according to the type of affected tissue; the most common type is hepatocerebral form, which is attributed to mutations in nuclear genes such as DGUOK and MPV17. These two genes encode mitochondrial proteins and play major roles in mtDNA synthesis. CASE PRESENTATION: In this investigation patients in three families affected by hepatocerebral form of MDS who were initially diagnosed with tyrosinemia underwent full clinical evaluation. Furthermore, the causative mutations were identified using next generation sequencing and were subsequently validated using sanger sequencing. The effect of the mutations on the gene expression was also studied using real-time PCR. A pathogenic heterozygous frameshift deletion mutation in DGUOK gene was identified in parents of two affected patients (c.706–707 + 2 del: p.k236 fs) presenting with jaundice, impaired fetal growth, low-birth weight, and failure to thrive who died at the age of 3 and 6 months in family I. Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months. A 5-month-old infant presenting with jaundice, dark urine, poor sucking, and feeding problems was also identified to have another novel mutation in MPV17 gene leading to stop gain mutation (c.277C > T: p.(Gln93*)). CONCLUSIONS: These patients had overlapping clinical features with tyrosinemia. MDS should be considered a differential diagnosis in patients presenting with signs and symptoms of tyrosinemia. |
format | Online Article Text |
id | pubmed-6819644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68196442019-10-31 Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series Mahjoub, Ghazale Habibzadeh, Parham Dastsooz, Hassan Mirzaei, Malihe Kavosi, Arghavan Jamali, Laila Javanmardi, Haniyeh Katibeh, Pegah Faghihi, Mohammad Ali Dastgheib, Seyed Alireza BMC Med Genet Case Report BACKGROUND: Mitochondrial DNA depletion syndromes (MDS) are clinically and phenotypically heterogeneous disorders resulting from nuclear gene mutations. The affected individuals represent a notable reduction in mitochondrial DNA (mtDNA) content, which leads to malfunction of the components of the respiratory chain. MDS is classified according to the type of affected tissue; the most common type is hepatocerebral form, which is attributed to mutations in nuclear genes such as DGUOK and MPV17. These two genes encode mitochondrial proteins and play major roles in mtDNA synthesis. CASE PRESENTATION: In this investigation patients in three families affected by hepatocerebral form of MDS who were initially diagnosed with tyrosinemia underwent full clinical evaluation. Furthermore, the causative mutations were identified using next generation sequencing and were subsequently validated using sanger sequencing. The effect of the mutations on the gene expression was also studied using real-time PCR. A pathogenic heterozygous frameshift deletion mutation in DGUOK gene was identified in parents of two affected patients (c.706–707 + 2 del: p.k236 fs) presenting with jaundice, impaired fetal growth, low-birth weight, and failure to thrive who died at the age of 3 and 6 months in family I. Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months. A 5-month-old infant presenting with jaundice, dark urine, poor sucking, and feeding problems was also identified to have another novel mutation in MPV17 gene leading to stop gain mutation (c.277C > T: p.(Gln93*)). CONCLUSIONS: These patients had overlapping clinical features with tyrosinemia. MDS should be considered a differential diagnosis in patients presenting with signs and symptoms of tyrosinemia. BioMed Central 2019-10-29 /pmc/articles/PMC6819644/ /pubmed/31664948 http://dx.doi.org/10.1186/s12881-019-0893-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Mahjoub, Ghazale Habibzadeh, Parham Dastsooz, Hassan Mirzaei, Malihe Kavosi, Arghavan Jamali, Laila Javanmardi, Haniyeh Katibeh, Pegah Faghihi, Mohammad Ali Dastgheib, Seyed Alireza Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series |
title | Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series |
title_full | Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series |
title_fullStr | Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series |
title_full_unstemmed | Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series |
title_short | Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series |
title_sort | clinical and molecular characterization of three patients with hepatocerebral form of mitochondrial dna depletion syndrome: a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819644/ https://www.ncbi.nlm.nih.gov/pubmed/31664948 http://dx.doi.org/10.1186/s12881-019-0893-9 |
work_keys_str_mv | AT mahjoubghazale clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT habibzadehparham clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT dastsoozhassan clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT mirzaeimalihe clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT kavosiarghavan clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT jamalilaila clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT javanmardihaniyeh clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT katibehpegah clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT faghihimohammadali clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries AT dastgheibseyedalireza clinicalandmolecularcharacterizationofthreepatientswithhepatocerebralformofmitochondrialdnadepletionsyndromeacaseseries |